CD44 and breast carcinoma: In addition, pKAL inhibited expressions of the proteins (CD44, Oct 3/4, β-catenin and MMP-9) that are assumed to be related to the RT resistance of RT-R-MDA-MB-231 human breast cancer cells [9].